A COVID-19 vaccine developed by Russia's Vector State Research Center of Virology and Biotechnology appears to be safe in early tests in humans, the media has reported. The agency said that clinical trials of the 'EpiVacCorona' vaccine will be completed in September. To date, the first vaccination was administered to 57 volunteers, while 43 received placebo," the agency said in a statement, adding that no side effects were observed in the volunteers who received the vaccine. Earlier this month, Russia registered the 'Sputnik V', becoming the first country to approve a Covid-19 vaccine. Media reports this week said that Russia is now planning a large-scale trial of its 'Sputnik V' vaccine involving 40,000 people.

Source: dna August 22, 2020 06:45 UTC